EFA Stock News EAFE Index MSCI Ishares (EFA) 66.13 08/02/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
EAFE Index MSCI Ishares (EFA) 66.13 $EFA

After Yesterday's Decline of 1.67%, iShares MSCI EAFE Index Fund Offers Investors Better Value
Comtex SmarTrend(R) - Thu Jul 31, 4:13PM CDT
iShares MSCI EAFE Index Fund (NYSE:EFA) traded in a range yesterday that spanned from a low of $66.52 to a high of $67.12. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $67.46 on volume of 25.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

The Week Ahead for Global Markets - Analyst Blog
John Blank - Zacks Investment Research - Mon Jul 21, 2:11PM CDT
The obvious geopolitical events in the Ukraine and Israel must square off with 700 earnings reports this week.

How to Use Just 4 iShares ETFs to Invest Simply and Effectively
Dan Caplinger, The Motley Fool - Motley Fool - Sun Jul 20, 9:05AM CDT
Investing doesn't have to be difficult. Exchange-traded funds let you invest simply but effectively with just a few different pieces to your portfolio. In the following video, Dan Caplinger, The Motley Fool's director of investment planning, looks...

Look for Shares of iShares MSCI EAFE Index Fund to Potentially Rebound after Yesterday's 1.28% Sell Off
Comtex SmarTrend(R) - Thu Jul 17, 4:12PM CDT
iShares MSCI EAFE Index Fund (NYSE:EFA) traded in a range yesterday that spanned from a low of $67.31 to a high of $68.10. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $67.51 on volume of 14.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

SmarTrend Watching for Potential Rebound in Shares of iShares MSCI EAFE Index Fund After 1.05% Loss
Comtex SmarTrend(R) - Tue Jul 08, 4:18PM CDT
iShares MSCI EAFE Index Fund (NYSE:EFA) traded in a range yesterday that spanned from a low of $67.78 to a high of $68.29. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $68.58 on volume of 11.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

iShares MSCI EAFE Index Fund Falls 2.43% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Jun 25, 3:42PM CDT
iShares MSCI EAFE Index Fund (NYSE:EFA) traded in a range yesterday that spanned from a low of $67.88 to a high of $68.28. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $69.84 on volume of 17.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Top Ranked Foreign Large Cap ETF in Focus: FNDF - ETF News And Commentary
Zacks Equity Research - ZACKS - Fri Jun 20, 9:00AM CDT
If you are seeking exposure to the large cap market beyond American shores, consider this ETF from Schwab.

Why Paying Off Your House Early May Be the Wrong Choice
Chuck Saletta, The Motley Fool - Motley Fool - Mon Jun 09, 1:10PM CDT
Personal finance guru and radio talk show host Dave Ramsey uses a series of seven steps -- what he calls the "baby steps" -- to help people take control of their financial lives. Ramsey's baby steps provide a common-sense approach that works for...

Stock Market And Funds Beat 'Sell In May And Go Away'
at Investor's Business Daily - Tue Jun 03, 5:37PM CDT
Fund investors last month were spared from the seasonal weakness in the stock market known as "sell in May and go away." The market shrugged off news that U.S. gross domestic product shrank 1% in the first quarter. The S&P 500 added 2% for the month...

Retirement Planning: ETF Portfolios Ascended In May
at Investor's Business Daily - Fri May 30, 5:43PM CDT
NorthCoast Asset Management's ETF retirement portfolios scored impressive gains in May as equity markets thrived. The S&P 500 set an all-time high during the month as jobless claims fell and investors shook off news of a decline in GDP in Q1. Foreign...

First Week Of March 2015 Options Trading For IShares MSCI EAFE Index Fund (EFA)
at The Street - Wed Mar 26, 9:55AM CDT
Investors in iShares MSCI EAFE Index Fund saw new options begin trading this week, for the March 2015 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 359 days until expiration...

SmarTrend Watching for Potential Pullback in Shares of iShares MSCI EAFE Index Fund After 1.09% Gain
Comtex SmarTrend(R) - Tue Mar 25, 3:43PM CDT
iShares MSCI EAFE Index Fund (NYSE:EFA) traded in a range yesterday that spanned from a low of $65.63 to a high of $66.19. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $65.81 on volume of 20.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Watch for iShares MSCI EAFE Index Fund to Potentially Rebound After Falling 1.86% Yesterday
Comtex SmarTrend(R) - Thu Mar 13, 3:42PM CDT
iShares MSCI EAFE Index Fund (NYSE:EFA) traded in a range yesterday that spanned from a low of $65.14 to a high of $66.69. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $66.01 on volume of 35.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

EFA May 2nd Options Begin Trading
at The Street - Thu Mar 13, 10:50AM CDT
Investors in iShares MSCI EAFE Index Fund saw new options begin trading today, for the May 2nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the EFA options chain for the new May 2nd contracts and identified one...

NorthCoast ETF Retirement Portfolios End February On A High Note
at Investor's Business Daily - Fri Feb 28, 5:39PM CST
NorthCoast Asset Management saw its ETF retirement portfolios heat up in February, with all holdings ending the month higher. After an icy start to 2014, top holdings have caught fire. The S&P 500 pushed to record heights during the month and...

Ukraine's Lesson for Investors: Know What's in Your ETFs
at The Street - Mon Feb 24, 10:02AM CST
Many ETFs have overly large exposures that can create headaches for their holders.

3 Foreign Small Cap ETFs Likely to Outperform - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 9:00AM CST
While foreign large cap ETFs have struggled, these are looking quite solid right now.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 29

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 23

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 17

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 16

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 22

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 23

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Context Therapeutics Gains Confidence with Strategic Developments

Updated Category News Views 60

Piper Sandler's Renewed Confidence in Context Therapeutics Piper Sandler has reiterated an Overweight rating for Context Therapeutics (NASDAQ: CNTX), maintaining a price target of $4.50 for the stock. This endorsement underscores their belief in the company’s potential within the biopharmaceutical sector. Positive Data from Competitors Enhances Expectations This renewed...

Continue Reading
Actinium's ATNM-400: A Promising Frontier in Prostate Cancer Therapy

Updated Category News Views 167

Introduction to ATNM-400's Innovative Approach Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) has announced compelling preclinical data showcasing its innovative treatment, ATNM-400. This first-in-class antibody radioconjugate targets a unique, non-PSMA antigen, revolutionizing prostate cancer therapy. ATNM-400 offers noteworthy therapeutic activity independent of...

Continue Reading
Opportunity Knocks: Ligon's Major Auction Up for Bids

Updated Category News Views 17

Equipment Auction Offers Unique Buying Opportunity Catch this: Ligon Co.'s auction is like finding a needle in a haystack in a world of overpriced equipment. We're talking about a smorgasbord of heavy machinery up for online grabs, and it’s happening until June 17. Auction Highlights: Your Next Business Asset? From telehandlers to trailers, this ain't your everyday yard...

Continue Reading
Selector Enhances Service Delivery with AWS Marketplace Launch

Updated Category News Views 147

Selector Launches on AWS Marketplace for Better Accessibility Selector, a pioneer in AI-driven observability and network intelligence, is transforming how organizations manage their network operations. The company has launched its flagship platform on the Amazon Web Services (AWS) Marketplace, which makes it easier for customers to procure and deploy its powerful AI tools...

Continue Reading
Exploring the Surge in Decentralized Energy Storage Growth

Updated Category News Views 229

Decentralized Energy Storage Market Overview The Decentralized Energy Storage market is gaining remarkable traction, with significant insights indicating a shift towards sustainable energy solutions. Valued at approximately USD 10.88 billion, the market is anticipated to expand to a staggering USD 35.62 billion, exhibiting a compound annual growth rate (CAGR) of 15.98%...

Continue Reading